Inventor
DAVIS CHRIS
US31 patents
⚠️ This page may combine multiple inventors who share the name “DAVIS CHRIS”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
VERTEX PHARMA
16 patentsUS7767672B2Aug 3, 2010
Aminopyrimidines useful as kinase inhibitors
VERTEX PHARMA51 citations98
US7528142B2May 5, 2009
Aminopyrimidines useful as kinase inhibitors
VERTEX PHARMA67 citations98
US9340546B2May 17, 2016
Compounds useful as inhibitors of ATR kinase
VERTEX PHARMA57 citations97
US9650381B2May 16, 2017
Compounds useful as inhibitors of ATR kinase
VERTEX PHARMA19 citations92
US8969360B2Mar 3, 2015
Compounds useful as inhibitors of ATR kinase
VERTEX PHARMA25 citations92
US8367697B2Feb 5, 2013
Kinase inhibitors
VERTEX PHARMA28 citations92
US10787452B2Sep 29, 2020
Compounds useful as inhibitors of ATR kinase
VERTEX PHARMA5 citations84
US10392391B2Aug 27, 2019
Compounds useful as inhibitors of ATR kinase
VERTEX PHARMA4 citations84
US9670215B2Jun 6, 2017
Compounds useful as inhibitors of ATR kinase
VERTEX PHARMA11 citations84
US8957078B2Feb 17, 2015
Compounds useful as inhibitors of ATR kinase
VERTEX PHARMA19 citations84
US11370798B2Jun 28, 2022
Compounds useful as inhibitors of ATR kinase
VERTEX PHARMA1 citations73
US11117900B2Sep 14, 2021
Compounds useful as inhibitors of ATR kinase
VERTEX PHARMA2 citations73
US10800781B2Oct 13, 2020
Compounds useful as inhibitors of ATR kinase
VERTEX PHARMA2 citations73
US10093676B2Oct 9, 2018
Compounds useful as inhibitors of ATR kinase
VERTEX PHARMA3 citations73
US12187731B2Jan 7, 2025
Compounds useful as inhibitors of ATR kinase
VERTEX PHARMA0 citations62
US9663519B2May 30, 2017
Compounds useful as inhibitors of ATR kinase
VERTEX PHARMA0 citations42